Selection of vascular access devices is a collaborative, multifactorial process that includes patient factors, device characteristics, therapeutic issues, and duration of therapy. Infants and children have additional unique needs. Newer technology is focused on the reduction of complications associated with central venous access and the hazards posed to health care workers when inserting devices and providing patient care.
Get full access to this article
View all access options for this article.
References
1.
1. Broviac JW, Cole JJ, Scribner BH.A silicone rubber right atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet1973;136:602–6.
2.
2. Gyves J, Ensminger W, Neiderhuber J, et al. Totally implanted system for intravenous chemotherapy in patients with cancer. Am J Med1982;73:841–5.
3.
3. Pearl J, Goldstein L, Cerisi K.Improved methods in long-term venous access using the P.A.S. PortSurg Gynecol Obstet1991;173:313–5.
5. Forssmann W.Die Sondierung des rechten Herzens. Klin Wochenschr1929;8:2085.
6.
6. Goodwin M, Carlson I.The peripherally inserted central catheter: a retrospective look at three years of insertions. J Intravenous Nurs1993;16:92–103.
7.
7. Hoshal VL.Total intravenous nutrition with peripherally inserted silicone elastomer central venous catheters. Arch Surg1975;110:644.
9. Jones MG.Modified Seldinger techniques. Paper presented at the 12th Annual Conference of the National Association of Vascular Access Networks, San Diego, CA, 1998.
10.
10. Flowers JF, Ryan Jr JA, Gough JA.Catheter-related complications of total parenteral nutrition (TPN). IN TPN (2nd ed), Fischer JE (ed.). Little Brown and Company, Boston, 1991, pp 25–45.
11.
11. Ryder M.Vascular access devices. IN Nutrition Support Nursing Core Curriculum, Hennessy KA, Orr ME (eds.). American Society for Parenteral and Enteral Nutrition, Silver Spring, MD, 1996, pp 23–1–23–32.
12.
12. Intravenous Nurses Society. The registered nurse's role in vascular access device selection. J Intravenous Nurs1997;20:71–2.
13.
13. Boyer CL, Wade DC.The impact of compliance on quality outcomes in the home infusion population. J Intravenous Nurs1998;21:S161–S165.
14.
14. Borow M, Crowley JG.Evaluation of central venous catheter thrombogenicity. Acta Anaesth Scand1985;815:59–64.
15.
15. Vanek VW, Kupensky DT, Thompson DJ.Hypersensitivity-like reactions related to insertion of Aquavene-based midline and PICC catheters. J Intravenous Nurs1997;20:23–7.
16.
16. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med1993;119:1168–74.
17.
17. Lokich JJ, Bothe AJ, Benotti P, et al. Complications of and management of implanted venous access catheters. J Clin Oncol1985;3:710–7.
18.
18. Pegues D, Axelrod P, McClarren C, et al. Comparison of infections in Hickman and implanted port catheter in adult solid tumor patients. J Surg Oncol1992;49:156–62.
19.
19. Clark-ChristoffN, Watters VA, Sparks W, et al. Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. JPEN1992;16:403–07.
20.
20. Farkas JC, Liu N, Bleriot JP, et al. Single-versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med1992;93:277–82.
21.
21. Pemberton LB, Lyman B, Lander V, et al. Sepsis from triple-vs single-lumen catheters during TPN in surgical or critically ill patients. Arch Surg1986;121:591–4.
22.
22. Flowers RH, Schwenzer KJ, Lopel RF, et al. Efficacy of an attachable subcutaneous cufffor the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA1989;261:878–83.
23.
23. Maki DG, Cobb L, Garman JK, et al. An attachable silver-impregnated cufffor prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med1988;85:307–14.
24.
24. Groeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation of the effect of the silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg1993;218:206–10.
25.
25. Tennenberg S, Lieser M, McCurdy B, et al. A prospective randomized trial of an antibiotic-and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg1997;132:1348–51.
26.
26. Maki DG, Stolz SM, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med1997;127:257–66.
27.
27. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. a randomized, double-blind trial. Ann Intern Med1997;127:267–74.
28.
28. Raad I, Daruoiche R, Hachem R, et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis1996;173:418–24.
29.
29. Raad I, Darouiche R, Hachem, et al. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med1998;26:219–24.
30.
30. Russel LM, Weinstein RA.Antimicrobial-coated central venous catheters-icing on the cake or the staffof life? (Editorial). Crit Care Med1998;26:195–6.
31.
31. Gazitua R, Wilson K, Bistrian BR, et al. Factors determining peripheral vein tolerance to amino acid infusions. Arch Surg1979;114:897–900.
32.
32. Shuster MH.Parenteral nutrition. IN Core Curriculum for Nutrition Support Nursing (3rd ed), Hennesy KA, Orr ME (eds.). American Society for Parenteral and Enteral Nutrition, Silver Spring MD, 1996, pp 22–1–22–12.
33.
33. Shizgal HM, Knowles JB.Peripheral amino acids. IN TPN (2nd ed), Fischer JE (ed.). Little Brown and Company, Boston, 1991, pp 389–402.
35. McCormick DC, Knutsen CV, Griffin RE, et al. Pharmaceutical aspects of parenteral nutrition. IN Hyperalimentation a Guide for Clinicians, Kaminski MV (ed.). Marcel Dekker, New York, 1985, pp 537–89.
36.
36. Goldmann DA, Martin WT, Worthington JW.Growth of bacteria and fungi in TPN solutions. Am J Surg1973;126:314–8.
37.
37. Warner BW, Haygood MM, Davies SL, et al. A randomized, prospective trial of standard Hickman compared with Groshong central venous catheters in pediatric oncology patients. J Am Coll Surg1996;183:140–4.
38.
38. Deerojanawong J, Sawyer SM, Fink AM, et al. Totally implantable venous access devices in children with cystic fibrosis. Thorax1998;53:285–9.
39.
39. Eastridge B, Lefor AT.Complications of indwelling venous access devices in cancer patients. J Clin Oncol1995;13:233–8.
40.
40. Bour ES, Weaver AS, Yang HC, et al. Experience with the double-lumen silastic catheter for hemoaccess. Gynecol Obstet1990;171:33–9.
41.
41. Hadaway LC.Comparison of vascular access devices. Semin Oncol Nurs1995;11:154–66.
42.
42. Kyle KS, Myers JS.Peripherally inserted central catheters: Development of a hospital based program. J Intravenous Nurs1990;13:287–90.
43.
43. Winslow MN, Trammell L, Camp-Sorrell D.Selection of vascular access devices and nursing care. Semin Oncol Nurs1995;11:167–73.
44.
44. StovroffM, Teague WG.Intravenous access in infants and children. Ped Clin N Am1998;45:1373–93.
